FTH ▲ +2.4% - Faeth Therapeutics, Inc.
$FTH Faeth Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate PIKTOR in Combination with a Selective Estrogen Receptor Degrader in HR+/HER2- Advanced Breast Cancer
16-NOV-2026 07:01 AM ET
Share this post
More filings for $FTH
FTH - Faeth Therapeutics, Inc. - SEC Filing Update (13-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 13, 2026FTH - Faeth Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026FTH - Faeth Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $FTH filing history →💬 Comments
Loading comments…
Leave a comment
